Control Bionics Limited Stock: price and insider trades · Australia

Control Bionics Limited belongs to the Health Care sector. Filings by its managers are published through ASX. Between 30 October 2025 and 30 October 2026, 10 insiders published 17 filings.

The flow runs one way only: 5 insiders bought (10 purchases totalling €283k) and nobody sold on the market. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €94k from Stephen Rix, disclosed on 11 August 2026, or 0.59% of market capitalisation. The buyers include 5 senior executives.

The data flag 6 purchases as part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 29 October 2026, 9 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade.

With 17 filings in twelve months, the company is more active than the median of 5 filings across the 1,608 companies we follow on the same exchange. Our records for Control Bionics Limited go back to 2026, with 10 purchases and no sales on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from ASX. Past trades are no guide to future returns.